The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Liposomal irinotecan + 5-fluorouracil + leucovorin + bevacizumab as second-line therapy in metastatic colorectal cancer (IRIS): A multi-center, single-arm, prospective, phase II study.
 
Xuhua Hu
No Relationships to Disclose
 
Bo Jiang
No Relationships to Disclose
 
Lu Hongxia
No Relationships to Disclose
 
Bin Yu
No Relationships to Disclose
 
Bo Yi
No Relationships to Disclose
 
Yudong Wang
No Relationships to Disclose
 
Lingjun Zhu
No Relationships to Disclose
 
Shengmian Li
No Relationships to Disclose
 
Baokun Li
No Relationships to Disclose
 
Dalu Kong
No Relationships to Disclose
 
Zhiwu Wang
No Relationships to Disclose
 
Wenbo Niu
No Relationships to Disclose
 
Hongqing Ma
No Relationships to Disclose
 
Shanchuan Wang
No Relationships to Disclose
 
Yanglin Chen
No Relationships to Disclose
 
Chao Lin
No Relationships to Disclose
 
Rong Yang
No Relationships to Disclose
 
Weiyou Zhu
No Relationships to Disclose
 
Jia Liu
No Relationships to Disclose
 
Guiying Wang
No Relationships to Disclose